secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001493152-25-026697
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma raises ~$93.7M net via 19.1M share and warrant offering at $5.10
--------------------------------------------------------------------------------

- 19,117,646 shares at $5.10/share and 490,196 pre-funded warrants at $5.09/warrant in underwritten offering.
- Net proceeds expected ~$93.7M after underwriting discounts and estimated expenses.
- Underwriting agreement with Morgan Stanley & Co. LLC as representative of underwriters.
- Offering expected to close December 9, 2025, subject to customary closing conditions.
- Pre-funded warrants exercisable immediately at $0.01/share, with 4.99% beneficial ownership limitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315225026697/0001493152-25-026697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315225026697/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-026697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer